Literature DB >> 15308578

Efficacy in CB1 receptor-mediated signal transduction.

Allyn C Howlett1.   

Abstract

CB(1) receptor cellular signal transduction is dependent on the expression of G proteins to which the receptor couples, the potential for precoupling of particular G proteins to the receptors either by scaffolding mechanisms or colocalization in lipid raft domains, and the effector mechanisms that these transducer molecules regulate. This discourse will evaluate studies of efficacy for CB(1) receptor-Gi/o activation at the molecular level. Evidence for brain regional differences in CB(1) receptor signal transduction efficacy and agonist selectivity for G proteins will be summarized. The possibility that CB(1) receptors interact with Gs or Gq will be evaluated, and questions with regard to the constitutive activity and G protein sequestration will be posed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308578      PMCID: PMC1575189          DOI: 10.1038/sj.bjp.0705881

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  72 in total

1.  Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.

Authors:  G Griffin; P J Atkinson; V M Showalter; B R Martin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1998-05       Impact factor: 4.030

Review 2.  Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry.

Authors:  T Kenakin
Journal:  Trends Pharmacol Sci       Date:  1997-12       Impact factor: 14.819

3.  LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation.

Authors:  C C Felder; K E Joyce; E M Briley; M Glass; K P Mackie; K J Fahey; G J Cullinan; D C Hunden; D W Johnson; M O Chaney; G A Koppel; M Brownstein
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

4.  Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

Authors:  I B Adams; D R Compton; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

5.  Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.

Authors:  D B Houston; A C Howlett
Journal:  Cell Signal       Date:  1998-10       Impact factor: 4.315

6.  Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes.

Authors:  C Sánchez; I Galve-Roperh; D Rueda; M Guzmán
Journal:  Mol Pharmacol       Date:  1998-11       Impact factor: 4.436

7.  Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.

Authors:  J Y Shim; E R Collantes; W J Welsh; B Subramaniam; A C Howlett; M A Eissenstat; S J Ward
Journal:  J Med Chem       Date:  1998-11-05       Impact factor: 7.446

8.  Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors.

Authors:  S J MacLennan; P H Reynen; J Kwan; D W Bonhaus
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

9.  Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.

Authors:  C S Breivogel; D E Selley; S R Childers
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

10.  Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes.

Authors:  M H Rhee; M Bayewitch; T Avidor-Reiss; R Levy; Z Vogel
Journal:  J Neurochem       Date:  1998-10       Impact factor: 5.372

View more
  23 in total

1.  Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation.

Authors:  Nina Wettschureck; Mario van der Stelt; Hiroshi Tsubokawa; Heinz Krestel; Alexandra Moers; Stefania Petrosino; Günther Schütz; Vincenzo Di Marzo; Stefan Offermanns
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

2.  Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids.

Authors:  Lance R McMahon
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

3.  The orphan receptor GPR55 is a novel cannabinoid receptor.

Authors:  E Ryberg; N Larsson; S Sjögren; S Hjorth; N-O Hermansson; J Leonova; T Elebring; K Nilsson; T Drmota; P J Greasley
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

4.  A cannabinoid receptor 1 mutation proximal to the DRY motif results in constitutive activity and reveals intramolecular interactions involved in receptor activation.

Authors:  Aaron M D'Antona; Kwang H Ahn; Lei Wang; Dale F Mierke; Jean Lucas-Lenard; Debra A Kendall
Journal:  Brain Res       Date:  2006-07-31       Impact factor: 3.252

Review 5.  The acute effects of cannabinoids on memory in humans: a review.

Authors:  Mohini Ranganathan; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2006-09-26       Impact factor: 4.530

6.  Cannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors.

Authors:  Robert H Pietrzak; Yiyun Huang; Stefani Corsi-Travali; Ming-Qiang Zheng; Shu-fei Lin; Shannan Henry; Marc N Potenza; Daniele Piomelli; Richard E Carson; Alexander Neumeister
Journal:  Neuropsychopharmacology       Date:  2014-05-12       Impact factor: 7.853

7.  Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  Methods Enzymol       Date:  2017-07-19       Impact factor: 1.600

8.  CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  J Basic Clin Physiol Pharmacol       Date:  2016-05-01

Review 9.  Amygdala FAAH and anandamide: mediating protection and recovery from stress.

Authors:  Ozge Gunduz-Cinar; Matthew N Hill; Bruce S McEwen; Andrew Holmes
Journal:  Trends Pharmacol Sci       Date:  2013-10-25       Impact factor: 14.819

10.  Discriminative stimulus functions of methanandamide and delta(9)-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol.

Authors:  Torbjörn U C Järbe; Chen Li; Subramanian K Vadivel; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.